VERAXA Biotech GmbH Appoints Dr. Lars Hufnagel to Chief Technical Officer

Lars Hufnagel will be responsible for advancing VERAXA’s antibody screening and ADC technologies by further developing its droplet-based microfluidic screening technology.HEIDELBERG, Germany, March 14, 2022 / B3C newswire / -- Dr. Lars Hufnagel has been appointed Chief Technical Officer (CTO) of VERAXA Biotech, base...

Related Keywords

Germany ,Heidelberg ,Baden Wüberg ,Lars Hufnagel ,Christoph Antz ,Araxa Biosciences Gmb ,Bruker Corporation ,European Molecular Biology Laboratory ,Group Leader Of The Cell Biology ,Chief Technical Officer ,General Manager ,Vice President ,Group Leader ,Cell Biology ,Biophysics Unit ,Velabs Therapeutics Gmbh ,Araxa Biosciences Gmbh ,High Throughput Screening Assays ,Mass Screening ,Precision Medicine ,Drug Screening Assays ,Computational Biology ,Biological Science Disciplines ,